Article Sidebar
Published:
Sep 16, 2008Keywords:
Hyperglycaemia <i>Vernonia amygdalina</i> liver function liver histology
Article Details
Issue
Section
Articles
Copyright of articles published shall reside exclusively with the Faculty of Pharmaceutical Sciences, University of Jos.
DECLARATION & COPYRIGHT TRANSFER
I/We the undersigned author(s) of article entitled
…………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………
Declare as follows:
- The manuscript submitted to Journal of Pharmacy & Bioresources is original and has not been and will be published, whole or in part, in print or electronic format, in any other journal. It is also not being currently considered for publication in any journal.
- The submitted manuscript is a joint decision of all the coauthors.
- Each author has participated sufficiently in the work to warrant his or her inclusion in the list of authors. To this end, each author takes responsibility for appropriate portions of the manuscript.
- Authors have obtained necessary approval to carry out the experiments on animals and human subjects. Approval certificates will be furnished, if required by publishers or editors of the journal.
- Authors do not have any conflict of interest (financial or otherwise) other than those declared.
- If the manuscript is accepted for publication, the authors transfer and assign copyright of the article referenced above to Journal of Pharmacy and Bioresources.
Name & Signature of authors
1. 2.
- 4.
- 6.
- 8.
Corresponding authors name address, affiliation and email:
Main Article Content
Effect of Vernonia amygdalina Del. on liver function in alloxan-induced hyperglycaemic rats
Abstract
The protective effect of ethanolic leaf-extract of an anti-diabetic plant, Vernonia amygdalina Del. on hepatic cell architecture and some biochemical indices of liver function has been studied in alloxanized Wistar rats. Twenty-one rats (120-160g) were included in the study and assigned to 3 groups of 7 rats each. Groups 1 and 2, normal and diabetic controls received placebo treatment, whereas group 3 the experimentally diabetic rats administered the plant extract (400mg/kg body weight) by gastric intubation for 14 days. Serum aminotransferase activities, significantly raised (P<0.05) in diabetic control group (15.75+ 1.75 and 37.81+ 7.62 respective for alanine and aspartate aminotransferase) relative to their respective normal control values (5.02 + 1.79 and 12.22 + 1.24) were decreased significantly (P<0.05) following treatment with the extract (8.57 + 2.69 and 18.90 + 1.37) representing 45.59% and 50.01% decrease respectively. Alkaline phosphatase activity follow a similar trend: Diabetic extract treated values (307.06 + 54.42) decreased significantly with respect to diabetic untreated (433.08 + 29.96) a 19.75 %. Serum protein total and albumin levels were respectively increased (7.54 + 0.60 and 3.18 + 0.27) compared to their diabetic control values (6.45 + 0.60 and 2.88 + 0.88). However, the increase was only significant (P<0.05) for albumin. Histological studies reveal for the extract treated group a restoration of hepatocyte degeneration, cellular sequestration and disoriented architecture observed in diabetic control group. Vernonia amygdalina Del. therefore can protect against hyperglycemia induced hepatotoxicity, besides its hypoglycaemic action
Keywords: Hyperglycaemia, Vernonia amygdalina, liver function, liver histology
Journal of Pharmacy and Bioresources Vol. 4 (1) 2007: pp. 25-31
